The Prophet and The Liar

Nancy Lublin - Texting That Saves Lives

Color Theory

fyeaharttips:

A color theory tutorial that may be long, but it’s worth reading all the way through:

http://purplekecleon.deviantart.com/gallery/?q=color#/d31xj5t

source: http://purplekecleon.deviantart.com/

This was submitted by our new co-mod sadistickitty! So excited you’re here :»

Sorry I’ve been afk for a while

ucsdhealthsciences:

In these scanning electron micrographs from Thomas Deerinck at the National Center for Microscopy and Imaging Research at UC San Diego, multitudinous HIV-1 particles exit from a cultured HeLa cell. The image is false-colored.
HIV prevention in a pill
Just three decades ago, a diagnosis of HIV/AIDS was akin to a death sentence. Infected persons often had just months to live. A lot has changed, particularly since the advent of antiretroviral drugs. Prescribed in the early stages of the infection, these drugs (usually taken in combination) often reduce HIV/AIDS to a chronic but livable condition. Patients can enjoy relatively normal, full lives for decades after diagnosis.
HIV/AIDS research may be on the cusp of the next, big advancement: Today, the California HIV/AIDS Research Program of the University of California announced three grants totaling more than $11 million to test a potential HIV prevention pill among high-risk HIV-uninfected persons in California. One of the teams is based at UC San Diego and headed by lead project investigator Richard Haubrich, MD, a professor in the UC San Diego School of Medicine and Antiviral Research Center.
Haubrich, with colleagues at UC San Diego and elsewhere, will enroll 400 study participants identified at high-risk of contracting an HIV/AIDS infection. (These are uninfected men who have sex with men or transgender women, all living in San Diego, Los Angeles and Long Beach). Each study participant will receive with a daily pill that combines two antiretroviral drugs (tenofovir and emtricitabine), manufactured and provided for the study by Gilead Sciences, Inc. The prevention pill is part of a larger intervention effort called “Pre-Exposure Prophylaxis with antiretroviral drugs” or PrEP. The researchers will also develop and study ways to help identify, engage and retain HIV-infected persons in interventional treatment programs. 
“There is no question that biomedical HIV prevention strategies, such as PrEP in HIV-uninfected and initiation of early antiretroviral therapy in HIV-infected people, can prevent future HIV infection,” said Haubrich. “The key is to empower people to initiate and maintain strict adherence to therapy. Ultimately, we hope these efforts will result in a reduction of new HIV infections in high-risk populations and improved clinical outcome for those who are currently HIV-infected.”
The UC San Diego-based program received a $5.6 million grant and will run for four years. The other two, related efforts are based at UC Los Angeles and the East Bay AIDS Center in Oakland.  You can read the full news release from the UC Office of the President here.

ucsdhealthsciences:

In these scanning electron micrographs from Thomas Deerinck at the National Center for Microscopy and Imaging Research at UC San Diego, multitudinous HIV-1 particles exit from a cultured HeLa cell. The image is false-colored.

HIV prevention in a pill

Just three decades ago, a diagnosis of HIV/AIDS was akin to a death sentence. Infected persons often had just months to live. A lot has changed, particularly since the advent of antiretroviral drugs. Prescribed in the early stages of the infection, these drugs (usually taken in combination) often reduce HIV/AIDS to a chronic but livable condition. Patients can enjoy relatively normal, full lives for decades after diagnosis.

HIV/AIDS research may be on the cusp of the next, big advancement: Today, the California HIV/AIDS Research Program of the University of California announced three grants totaling more than $11 million to test a potential HIV prevention pill among high-risk HIV-uninfected persons in California. One of the teams is based at UC San Diego and headed by lead project investigator Richard Haubrich, MD, a professor in the UC San Diego School of Medicine and Antiviral Research Center.

Haubrich, with colleagues at UC San Diego and elsewhere, will enroll 400 study participants identified at high-risk of contracting an HIV/AIDS infection. (These are uninfected men who have sex with men or transgender women, all living in San Diego, Los Angeles and Long Beach). Each study participant will receive with a daily pill that combines two antiretroviral drugs (tenofovir and emtricitabine), manufactured and provided for the study by Gilead Sciences, Inc. The prevention pill is part of a larger intervention effort called “Pre-Exposure Prophylaxis with antiretroviral drugs” or PrEP. The researchers will also develop and study ways to help identify, engage and retain HIV-infected persons in interventional treatment programs. 

“There is no question that biomedical HIV prevention strategies, such as PrEP in HIV-uninfected and initiation of early antiretroviral therapy in HIV-infected people, can prevent future HIV infection,” said Haubrich. “The key is to empower people to initiate and maintain strict adherence to therapy. Ultimately, we hope these efforts will result in a reduction of new HIV infections in high-risk populations and improved clinical outcome for those who are currently HIV-infected.”

The UC San Diego-based program received a $5.6 million grant and will run for four years. The other two, related efforts are based at UC Los Angeles and the East Bay AIDS Center in Oakland.  You can read the full news release from the UC Office of the President here.

abeiramar:

I shared this link a long time ago in my plurk and I’m going to share it now. Since I have so few followers I don’t care. 

That blog has hundreds of How to Draw books and art related stuff from software to artbooks. You can find some RARE gems there and some great highly renowned books like Andrew Loomis and Richard Williams’s The Animator’s Survival Kit.

Edit: Fixed the link lol, if it’s still not working just copy/paste http://eddiesekiguchi.blogspot.pt/ on your browser.

(via the-art-post)

ucsdhealthsciences:

Detecting brain cancer without surgery
Currently, there is no way to accurately diagnose the presence of a brain tumor without actually cutting into the skull. Nor is there a reliable method for monitoring the progression of brain cancer. But in a paper, published online this week in the journal Neuro-Oncology, Santosh Kesari, MD, PhD, director of Neuro-Oncology at UC San Diego Moores Cancer Center, with colleagues at the Brigham and Women’s Hospital and elsewhere describe a non-surgical method that may do both with remarkable accuracy.            In a study of 118 patients with different types of brain cancer, researchers focused on the presence and abundance of different microRNAs in patients’ cerebrospinal fluid (CSF).  MicroRNAs are short, single-stranded RNA molecules that help regulate gene expression. They have proven to be effective biomarkers for other conditions and can be accurately measured simply and inexpensively.            That utility appears to hold true for brain cancer as well. The scientists report that they found significantly increased levels of two specific types of miRNA in the CSF of patients with glioblastoma and brain metastasis of breast and lung cancer, compared to tumors in remission and a variety of non-neoplastic conditions.             Patients with brain metastases but no other pathologic conditions showed highly elevated levels of other types of miRNA, allowing researchers to discriminate between glioblastoma and metastatic brain tumors.            The scientists were able to achieve these diagnoses by measuring as few as seven miRNAs. Their accuracy rate was 91 to 99 percent.            In addition, they reported that disease activity and treatment response can be monitored by regularly profiling microRNA levels in the CSF of glioblastoma and non-small cell lung carcinoma patients.            “We are excited about the potential that this test has to ease the process of detecting and monitoring brain tumors,” said senior author Anna M. Krichevsky, PhD, of the Center of Neurologic Diseases at Brigham and Women’s Hospital in Boston. “The test needs to be further developed before it is used in a clinical setting, but I expect it could be particularly valuable for patients who are not surgical candidates due to the tumor’s size or location, or due to an underlying medical condition.”      

ucsdhealthsciences:

Detecting brain cancer without surgery

Currently, there is no way to accurately diagnose the presence of a brain tumor without actually cutting into the skull. Nor is there a reliable method for monitoring the progression of brain cancer. But in a paper, published online this week in the journal Neuro-Oncology, Santosh Kesari, MD, PhD, director of Neuro-Oncology at UC San Diego Moores Cancer Center, with colleagues at the Brigham and Women’s Hospital and elsewhere describe a non-surgical method that may do both with remarkable accuracy.
           
In a study of 118 patients with different types of brain cancer, researchers focused on the presence and abundance of different microRNAs in patients’ cerebrospinal fluid (CSF).  MicroRNAs are short, single-stranded RNA molecules that help regulate gene expression. They have proven to be effective biomarkers for other conditions and can be accurately measured simply and inexpensively.
           
That utility appears to hold true for brain cancer as well. The scientists report that they found significantly increased levels of two specific types of miRNA in the CSF of patients with glioblastoma and brain metastasis of breast and lung cancer, compared to tumors in remission and a variety of non-neoplastic conditions.
           
Patients with brain metastases but no other pathologic conditions showed highly elevated levels of other types of miRNA, allowing researchers to discriminate between glioblastoma and metastatic brain tumors.
           
The scientists were able to achieve these diagnoses by measuring as few as seven miRNAs. Their accuracy rate was 91 to 99 percent.
           
In addition, they reported that disease activity and treatment response can be monitored by regularly profiling microRNA levels in the CSF of glioblastoma and non-small cell lung carcinoma patients.
           
“We are excited about the potential that this test has to ease the process of detecting and monitoring brain tumors,” said senior author Anna M. Krichevsky, PhD, of the Center of Neurologic Diseases at Brigham and Women’s Hospital in Boston. “The test needs to be further developed before it is used in a clinical setting, but I expect it could be particularly valuable for patients who are not surgical candidates due to the tumor’s size or location, or due to an underlying medical condition.”      

silverruby:

Thank you for everyone who attended the first session, I will upload the video to youtube if I can. For now the full session is available at: http://www.livestream.com/silverrubyworkshops

I apologize if the first session is confusing, but it will be easier to understand the tools as I present…

adrhaze:

http://scionoftheveil.com/

My comic project Scion of the Veil is finally ready to be shared. I hope you will enjoy what’s online right now, and every next friday there will be a new page untill I run out of finished pages! [hopefully not too soon]

If you are familiar with my work, you will have an idea what to expect from this story. I would describe it as an “erotic fantasy romance comedy drama” :P expect lots of shirtless horned men, monsters and purple, lots and lots of purple. And also porn, because that’s just how I roll. I’m very excited to keep working on it, and hopefully entertain a few people along the way.

I’d really appreciate a reblog if you like what you see!

(via silverruby)